- (a) There is established as a special fund the Board of Pharmacy Fund ("Fund"), which shall be administered by the Department of Health in accordance with subsection (c) of this section.
(b)
- (1) All licensing fees, civil fines, and interest earned relating to the practice of pharmaceutical detailing shall be deposited in the Fund.
- (2) For the purposes of this subsection, the term "practice of pharmaceutical detailing" shall have the same meaning as provided in § 3-1201.02(10A).
- (c) Money in the Fund shall be used for the administration of the Board of Pharmacy.
- (d) Any money remaining available in the Fund at the end of a fiscal year, as determined by the Chief Financial Officer in the fiscal year-end close, shall be transferred to the unassigned fund balance of the General Fund of the District of Columbia as part of the fiscal year-end close.
History
Oct. 3, 2001, D.C. Law 14-28, § 4904b
as added Mar. 26, 2008, D.C. Law 17-131, § 103, 55 DCR 1659
Dec. 6, 2025, D.C. Law 26-55, § 7080
Delegation of Authority
Delegation of Authority pursuant to D.C. Law 17-131, the SafeRX Amendment Act of 2008, see Mayor’s Order 2008-83, June 11, 2008 ( 55 DCR 9360).
Emergency Legislation
For temporary (90 days) amendment of this section, see § 7080 of Fiscal Year 2026 Budget Support Emergency Act of 2025 (D.C. Act 26-146, Sept. 3, 2025, 72 DCR 9623).
For temporary (90 days) amendment of this section, see § 7080 of Fiscal Year 2026 Budget Support Congressional Review Emergency Act of 2025 (D.C. Act 26-210, Nov. 24, 2025, 72 DCR 13514).